GForce Life Sciences connects highly targeted professionals to executives' needs.
Chicago, IL
Joined February 2016
- Tweets487
- Following69
- Followers88
- Likes31
GForce Life Sciences retweeted
3 Hurdles Ahead of Alnylam and Its Revolutionary New Drug: Taking a medical breakthrough from concept through commercial success is like ascending a mountain that grows taller and more treacherous with every setback. It's taken Alnylam Pharmaceuticals,… dlvr.it/Qg4Ch9
GForce Life Sciences retweeted
As biosimilars loom, Roche's Genentech plans to lay off 223 staffers in California: As Roche braces for the biosimilar assault on blockbuster cancer drugs, its Genentech unit is parting ways with 223 staffers in California. In a WARN notice posted on the… dlvr.it/Qg4NRR
GForce Life Sciences retweeted
Contact me if we can be of assistance for consultative support in any of these areas:
Pharmaceutical, Biotech, Medical Devices
#regulatory
#Quality
#medicalaffairs
#safety
#Research&development
#SupplyChain
#manufacturing
#LifeSciences
@GforceLife
GForce Life Sciences retweeted
Hey followers, go follow our Life Sciences page for updates in the industry and more compelling content! @GforceLife
#HappyFriday!!
GForce Life Sciences retweeted
UCLA developing battery-free implantable medical device that draws energy directly from human body→ buff.ly/2qIjbEp #cardiology
ALT null
GForce Life Sciences retweeted
Boston Sci wins one, loses one against Edwards in heart-valve patent fight fiercebiotech.com/medical-de… via @FierceMedDev
GForce Life Sciences retweeted
U.S. FDA grants Abbott first commercial authorization for a molecular test to detect Zika virus using whole blood: abbo.tt/2jHqq7m
GForce Life Sciences retweeted
Medtronic is reportedly looking to offload its medical supply biz, which could be worth up to $5 billion #meddevice massdevice.com/medtronic-loo…
GForce Life Sciences retweeted
Abbott closes its $25 billion purchase of St. Jude, which will now operate as a wholly-owned subsidiary massdevice.com/abbott-closes… #meddevice
GForce Life Sciences retweeted
Pfizer agrees to $100m haircut in Hospira infusion sale to ICU Medical: Mass Device dlvr.it/N3V6WM
GForce Life Sciences retweeted
Did you know that on average it takes twelve years to bring a new medicine to #patients? ow.ly/S8li307I6kU
GForce Life Sciences retweeted
#Abbott announces sale of vision business to Johnson & Johnson for $4.325 Billion abbo.tt/2cwQMs2
GForce Life Sciences retweeted
Mylan cuts patient cost of EpiPen in US after pressure over price increases firstwordpharma.com/node/141… $MYL #pharma
GForce Life Sciences retweeted
FDA is hell on wheels re manufacturing issues these days-- $ADMA CRL
finance.yahoo.com/news/adma-…
GForce Life Sciences retweeted
$ABBV Q2 2016 financial results are here. Learn what’s driving our growth: bit.ly/2a4v5R8
GForce Life Sciences retweeted
With the world's biggest biologics facing the patent cliff, biosimilars are big business buff.ly/2a3VxY0
GForce Life Sciences retweeted
Takeda inks another biotech pact as it pays $400M+ to TiGenix: ow.ly/GX7o301VAGH by @PharmaceuticBen